<DOC>
	<DOCNO>NCT01245647</DOCNO>
	<brief_summary>The purpose study find medication , naltrexone helpful HIV-infected woman sometimes drink much . The study try find whether woman like medication , whether medication help cut back drinking , whether help improve overall health . Naltrexone use widely among people engage less severe drink primary health care setting . Therefore , investigator would like determine whether helpful among woman sometimes drink 4 drink per occasion 7 drink per week . The investigator hypothesize take naltrexone , woman hazardous drink pattern reduce drink turn improve medication adherence , improve health quality life .</brief_summary>
	<brief_title>Will Having Alcohol Treatment Improve Functioning ?</brief_title>
	<detailed_description>The primary objective study evaluate acceptability effectiveness treatment program hazardous drinking , deliver within HIV-clinic outpatient setting , involve oral naltrexone . The central hypothesis woman randomize treatment program decrease rate hazardous drink improved clinical behavioral health outcome associate hazardous drinking . The investigator formulate hypothesis base exist literature , preliminary data clinical experience . The investigator hypothesize woman randomize receive alcohol treatment intervention less likely hazardous drink behavior 6-months enrollment , compare woman receive similar assessment formal treatment intervention . The investigator hypothesize 4-months enrollment , woman randomize receive alcohol treatment intervention improve adherence HIV antiretroviral therapy , improve CD4 cell count , reduce HIV viral load , reduce risky sexual behavior , compare woman receive similar assessment formal intervention . The investigator recruit 90 woman 3 different site Florida , Washington DC Chicago . Of 90 woman 60 receive naltrexone 30 receive placebo . Study participant take medication 4 month investigator follow 7 month . At baseline , 2 month , 4 month 7 month , investigator administer study questionnaire assess liver enzymes , CD4 count viral load . The investigator also follow month 1 3 reinforce medication intake ass possible side effect . New treatment option available , impact hazardous drinking yet evaluate among HIV-infected woman , many poor , minority , associate mental health substance abuse problem . Delivery therapeutic intervention must improve order reduce hazardous drink woman HIV/AIDS . The propose research significant therapy offer within HIV clinic setting potentially improve health population significantly undertreated . In addition determine effectiveness alcohol treatment intervention , investigator also identify key barrier facilitator associate adherence pharmacologic treatment alcohol woman hazardous drinking . The finding directly impact type quality care hazardous drinking subset HIV-infected individual inform primary secondary prevention effort</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Hazardous drinking : define NIAAA either follow : 1. binge drinking ( 4 drink per occasion least twice monthly ) , ( NIAAA 2005 ) OR 2. high quantityfrequency ( &gt; 7 drink per week ) Age 18 Female HIVinfected document rapid HIV test license ELISA test kit confirm repeat ELISA , Western Blot , HIV1 culture , HIV1 antigen , plasma HIV1 RNA viral load second antibody test method ELISA time prior study entry . Able understand comply plan study procedure . Willing able provide inform consent . Contraindications treatment naltrexone : current physiologic opiate dependence ; current daily prescription opioid medication ; positive urine drug test opioids ; allergic naltrexone ; significantly abnormal baseline liver enzyme ( AST ALT â‰¥ 5 time normal ) ; dialysis renal failure currently take oral medication tuberculosis . Currently pregnant positive pregnancy test . currently breastfeed . Currently take alcohol treatment medication ( disulfiram , topiramate , naltrexone , acamprosate ) . currently homeless , unable provide mail address , plan move area within next 7 month . Unable communicate English . Research coordinator assessment participant comprehend study consent procedure Has current prognosis less 1 year live Abnormal vital sign enrollment visit Currently treatment Hepatitis C ( HCV ) infection Prisoner status</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>woman</keyword>
	<keyword>HIV</keyword>
	<keyword>alcohol</keyword>
	<keyword>medication</keyword>
	<keyword>adherence</keyword>
	<keyword>acceptability</keyword>
</DOC>